Indian Journal of Critical Care Case Report

Register      Login

VOLUME 3 , ISSUE 4 ( July-August, 2024 ) > List of Articles


Postoperative Euglycemic Diabetic Ketoacidosis

Sanjana Anand, Rajavardhan Rangappa, Rajesh M Shetty

Keywords : Case report, Diabetic ketoacidosis, Euglycemic diabetic ketoacidosis, Postoperative diabetic ketoacidosis

Citation Information : Anand S, Rangappa R, Shetty RM. Postoperative Euglycemic Diabetic Ketoacidosis. 2024; 3 (4):109-110.

DOI: 10.5005/jp-journals-11006-0121

License: CC BY-NC 4.0

Published Online: 21-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Euglycemic diabetic ketoacidosis (EDKA) is a rare complication of diabetes associated with various risk factors like fasting, surgery, pregnancy, and the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors. Euglycemic diabetic ketoacidosis occurs mainly due to the imbalance between insulin and counterregulatory hormones. It can occur in both type 1 and type 2 diabetes mellitus. It is characterized by euglycemia associated with severe metabolic acidosis and ketosis. Diagnosis is very exigent due to its varied etiology and uncommon presentation with normal blood glucose levels resulting in delayed recognition. Hence, it is very important to suspect and diagnose at an early stage to prevent its complications. In our case report, we present a challenging case of postoperative EDKA not associated with the association of SGLT-2 inhibitors.

PDF Share
  1. Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: a review. Curr Diabetes Rev 2017;13:315–321. DOI: 10.2174/1573399812666160421121307
  2. Munro JF, Campbell IW, McCuish AC, et al. Euglycaemic diabetic ketoacidosis. Br Med J 1973;2:578–580. DOI: 10.1136/bmj.2.5866.578
  3. Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism 2016;65 507–521. DOI: 10.1016/j.metabol.2015.12.007
  4. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 1999;15:412–426. DOI: 10.1002/(sici)1520-7560(199911/12)15:6<412::aid-dmrr72>;2-8
  5. Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335–1343. DOI: 10.2337/dbib9-9032
  6. Barski L, Eshkoli T, Brandstaetter E, et al. Euglycemic diabetic ketoacidosis. Eur J Intern Med 2019;63:9–14. DOI: 10.1016/j.ejim.2019.03.014
  7. Rawla P, Vellipuram AR, Bandaru SS, et al. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma. Endocrinol Diabetes Metab Case Rep 2017;2017:17–81. DOI: 10.1530/EDM-17-0081
  8. Gelaye A, Haidar A, Kassab C, et al. Severe ketoacidosis associated with canagliflozin (Invokana): a safety concern. Case Rep Crit Care 2016;2016:1656182. DOI: 10.1155/2016/1656182
  9. Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care 2015;38:1638–1642. DOI: 10.2337/dc15-1380
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.